Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2675-2680

  Sesterhenn, Andreas M ^a   Mandic, Robert ^a   Dünne, Anja A ^a   Werner, Jochen A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cell lines; Cytokeratins; HNSCC; RT PCR

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 6; RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BIOPSY; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; KERATINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 22944462379     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Fuchs E: Keratins and the skin. Annu Rev Cell Dev Biol 11: 123-153, 1995.
2. Moll R, Franke WW, Schiller DL, Geiger B and Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24, 1982.
3. Moll R: Cytokeratins as Markers of Differentiation: Expression Profiles in Epithelia and Epithelial Tumors. Gustav Fischer, Stuttgart Jena (eds.). New York, 1993.
4. Moll R: Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 9: 63-69, 1994.
5. Moll R: Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 31: 205-262, 1998.
6. Ruud P, Fodslad O and Hovig E: Identification of a novel cytokeratin 19 pseudogen that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 80: 119-125, 1999.
7. Van der Velden LA, Schaafsma HE, Manni JJ, Ramaekers FC and Kuijpers W: Cytokeratin expression in normal and (pre)malignant head and neck epithelia: an overview. Head Neck 15: 133-146, 1993.
8. Van der Velden LA, Schaafsma HE, Manni JJ, Ruiter DJ, Ramaekers CS and Kuijpers W: Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol 254: 376-383, 1997.
9. Zhong XY, Kaul Sepp, Lin YS, Eichler A and Bastert G: Sensitive detection of micrometastases in hone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19. J Cancer Res Clin Oncol 126: 212-218, 2000.
10. Lansford C, Grenman R and Bier H: Head and neck cancers: In: Human Cell Culture Vol 2, Cancer Cell Lines part 2 (J Masters, ed.). Dordrecht, Kluwer Academic Press, pp. 185-255, 1999.
11. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
12. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
13. Batteiger B, Newhall WJ and Jones RB: The use of tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes. J Immunol Meth 55: 297-307, 1982.
14. Wood GS and Warnke R: Suppression of endogenous avidin-biotin activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 29: 1196-1204, 1981.
15. Kannan S, Balaram P, Chandran GJ, Pillai MR, Mathew B, Nalinakumari KR and Nair MK: Differential expression of cytokeratin proteins during tumor progression in oral mucosa. Epithelial Cell Biol. 3: 61-69, 1994.
16. Schaafsma HE and Ramaekers FCS: Cytokeratin subtyping in normal and neoplastic epithelium: basic principles and diagnostic applications. Pathol Annu Part 1 29: 21-62, 1994.
17. Terry RM, Gray C and Bird CC: Aberrent expression of low molecular weight cytokeratins in primary and secondary squamous carcinoma of the head and neck. J Laryngol Otol 100: 1283-1287, 1986.
18. Van der Velden LA, Schaafsma HE, Manni JJ, Link M, Ruiter DJ, Ramaekers FC and Kuijpers W: Cytokeratin and vimentin expression in normal epithelium and benign lesions of the vocal cords. Acta Otolaryngol 116: 325-331, 1996.
19. Becker MT, Shores CG, Yu KK and Yarbrough WG: Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130: 21-27, 2004.
20. Shores CG, Yin X, Funkhouser W and Yarbrough W: Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130: 937-942, 2004.
21. Mackay B and Ordonez NG: Pathological evaluation of neoplasms with unknown primary origin. Semin Oncol 20: 206-228, 1993.
22. Bostick P, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R and Hoon DSB: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632-2640, 1998.
23. Fishman A, Klein A, Zemer R, Zimlichman S, Bernheim J, Cohen I and Altaras MM: Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. Gyn Oncol 77: 399-404, 2000.
24. Ghossein RA, Carusone L and Bhattacharya S: Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas. In Vivo 14: 237-250, 2000.
25. Ghossein RA, Carusone L and Bhattacharya S: Review: Polymerase chain reaction of micrometastases and circulating tumor cells: application to melanoma, prostate and thyroid carcinomas. Diag Mol Path 8: 165-175, 1999.
26. Hamakawa H, Fukizumi M, Bao Y, Sumida T, Onishi A, Tanioka H, Sato H and Yumoto E: Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer. Clin Exp Metastasis 17: 593-599, 1999.
27. Hermanek P: Disseminated tumor cells versus micrometastasis: definitions and problems. Anticancer Res 19: 2771-2774, 1999.
28. Jung R, Petersen K, Krüger W, Wolf M, Zander A and Neumaier M: Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 81: 870-873, 1999.
29. Kijima F, Natsugoe S, Takao S, Aridome K, Baba M, Yoshifumi M, Eizuru Y and Aikou T: Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma. Oncology 58: 38-44, 2000.
30. McDonald LA, Walker DM and Gibbins JR: Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5. Oral Oncol 34: 276-283, 1998.
31. Miyake Y, Fujiwara Y, Ohue M, Yamamoto H, Sugita Y, Tomita N, Sekimoto M, Shiozaki H and Monden M: Quantification of micrometastasis in lymph nodes of colorectal cancer using real-time flourescence polymerase chain reaction. Int J Oncol 16: 289-293, 2000.